Friday 20 September 2024

Pharma & Biotech Start-up & Scale-up News

Featured

A Swiss biotech focused on developing therapies for autism spectrum disorder (ASD).
Pharmaceutical
Lexicon's sotagliflozin shows promise in glucose control
12 September 2024
Pharmaceutical
New data analysis shows benefit of Lexicon’s sotagliflozin
4 September 2024

Latest Ones To Watch News

Biotechnology
GCTx launches with bold cell therapy claim
19 September 2024
Biotechnology
Positive data from pivotal AGAVE-201 trial of Niktimvo published
19 September 2024
Pharmaceutical
FDA snubs Vanda Pharma's NDA for tradipitant in gastroparesis
19 September 2024
More ones to watch news >
Reset all filters
Refine Search
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics
Attovia Therapeutics
Ajax Therapeutics
Cartesian Therapeutics
AltruBio
Progentos Therapeutics
Aktis Oncology


Today's issue

Biotechnology
GCTx launches with bold cell therapy claim
19 September 2024
Biotechnology
Positive data from pivotal AGAVE-201 trial of Niktimvo published
19 September 2024
Pharmaceutical
FDA snubs Vanda Pharma's NDA for tradipitant in gastroparesis
19 September 2024
Biotechnology
Stalicla names chief scientific and clinical development advisor
19 September 2024
Pharmaceutical
Roche touts positive Phase III results with Xofluza
19 September 2024
Biotechnology
Syed Husain named BioCentriq boss
19 September 2024
Pharmaceutical
Applied Therapeutics stock surges after FDA update
19 September 2024

Company Spotlight

A Swiss biotech focused on developing therapies for autism spectrum disorder (ASD).




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze